Results 291 to 300 of about 478,784 (306)

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

British Journal of Cancer, 2016
Daoud Sie, Elisabeth Bloemena, E Thunnissen   +2 more
exaly  

Response to EGFR blockade

2021
VELCULESCU VICTOR, PAPP ENIKO, ADLEFF VILMOS, BERTOTTI ANDREA, TRUSOLINO LIVIO   +4 more
openaire   +4 more sources

Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study

Ca-A Cancer Journal for Clinicians
Da-Xing Zhu
exaly  

EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Cancer Cell
Muntadher Jihad, Joaquin Araos, Giulia Biffi   +2 more
exaly  

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

Oncogene, 2009
Federico Cappuzzo, M Varella-Garcia
exaly  

EGFR mutations

2009
openaire   +12 more sources

EGFR

openaire   +1 more source

EGFR-binding peptide

2014
IIMORI YUSUKE, YAMAGATA MIZUE, SHIONO TOMOTAKA   +2 more
openaire   +5 more sources

EGFR-BASED PEPTIDES

2012
SCHROEDER JOYCE A, BITLER BENJAMIN G, GOVERDHAN AARTHI   +2 more
openaire   +3 more sources

HUMANIZED EGFR ANTIBODIES

2012
GOLETZ STEFFEN, DANIELCZYK ANTJE
openaire   +4 more sources